Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR
Sena Kim, Kidist Ashami, Sora Lim, Karl Staser, Kiran Vij, Srikanth Santhanam, Julie Ritchey, Sarah Peterson, Feng Gao, Matthew A. Ciorba, Matthew Cooper, John F. DiPersio, Jaebok Choi
Topics & Concepts
Graft-versus-host diseaseImmunologyMedicineHematologyCancer researchInternal medicineDiseasePharmacological Effects of Natural CompoundsVitamin C and Antioxidants ResearchExercise and Physiological Responses